SEC Comment Letter for BioScience Health Innovations, (BHIC) — Dec 17, 2019
BioScience Health Innovations, Inc.
Date: Dec. 17, 2019 · CIK: 0001784440 · Accession: 0000000000-19-016500
AI Filing Summary & Sentiment
File numbers found in text: 333-234487
Letter
December 17, 2019 Ivan Homici Chief Executive Officer Nowtransit, Inc. 20, Ayres Road Manchester England, M16 9NB Re:Nowtransit, Inc. Amendment No. 1 to Registration Statement on Form S-1 Filed December 6, 2019 File No. 333-234487 Dear Mr. Homici: We have reviewed your amended registration statement and have the following comment. In our comment, we may ask you to provide us with information so we may better understand your disclosure. Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe our comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to this comment, we may have additional comments. Unless we note otherwise, our references to prior comments are to comments in our November 26, 2019 letter. Amendment No. 1 to Registration Statement on Form S-1 Jumpstart Our Business Startups Act, page 4 1.We note from your revised disclosure in response to prior comment 1 that you have elected not to take advantage of the benefits of the extended transition period. Please revise disclosures throughout your filing to be consistent with this decision. In this regard, remove statements indicating that your financial statements may not be comparable to other public companies, and disclose that this decision is irrevocable. Refer to Question 13 of the Generally Applicable Questions on Title I of the JOBS Act available on our website at https://www.sec.gov/divisions/corpfin/guidance/cfjjobsactfaq-title-i- general.htm.
FirstName LastNameIvan Homici Comapany NameNowtransit, Inc. December 17, 2019 Page 2 FirstName LastName Ivan Homici Nowtransit, Inc. December 17, 2019 Page 2 You may contact Joyce Sweeney, Staff Accountant, at (202) 551-3449 or Kathleen Collins, Accounting Branch Chief, at (202) 551-3499 if you have questions regarding comments on the financial statements and related matters. Please contact Matthew Derby, Staff Attorney, at (202) 551-3334 or Jan Woo, Legal Branch Chief, at (202) 551-3453 with any other questions. Sincerely, Division of Corporation Finance Office of Technology
Show Raw Text
December 17, 2019
Ivan Homici
Chief Executive Officer
Nowtransit, Inc.
20, Ayres Road
Manchester
England, M16 9NB
Re:Nowtransit, Inc.
Amendment No. 1 to Registration Statement on Form S-1
Filed December 6, 2019
File No. 333-234487
Dear Mr. Homici:
We have reviewed your amended registration statement and have the following
comment. In our comment, we may ask you to provide us with information so we may better
understand your disclosure.
Please respond to this letter by amending your registration statement and providing the
requested information. If you do not believe our comment applies to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
After reviewing any amendment to your registration statement and the information you
provide in response to this comment, we may have additional comments. Unless we note
otherwise, our references to prior comments are to comments in our November 26, 2019 letter.
Amendment No. 1 to Registration Statement on Form S-1
Jumpstart Our Business Startups Act, page 4
1.We note from your revised disclosure in response to prior comment 1 that you have
elected not to take advantage of the benefits of the extended transition period. Please
revise disclosures throughout your filing to be consistent with this decision. In this regard,
remove statements indicating that your financial statements may not be comparable to
other public companies, and disclose that this decision is irrevocable. Refer to Question
13 of the Generally Applicable Questions on Title I of the JOBS Act available on our
website at https://www.sec.gov/divisions/corpfin/guidance/cfjjobsactfaq-title-i-
general.htm.
FirstName LastNameIvan Homici
Comapany NameNowtransit, Inc.
December 17, 2019 Page 2
FirstName LastName
Ivan Homici
Nowtransit, Inc.
December 17, 2019
Page 2
You may contact Joyce Sweeney, Staff Accountant, at (202) 551-3449 or Kathleen
Collins, Accounting Branch Chief, at (202) 551-3499 if you have questions regarding comments
on the financial statements and related matters. Please contact Matthew Derby, Staff Attorney, at
(202) 551-3334 or Jan Woo, Legal Branch Chief, at (202) 551-3453 with any other questions.
Sincerely,
Division of Corporation Finance
Office of Technology